Background: This study was conducted to investigate the fertilization and embryo development of human oocytes injected at different time intervals after extrusion of the first polar body (PB) following in vitro maturation (IVM) in IVM cycles. Also, we evaluated whether spindle imaging could serve as a tool to determine the optimal ICSI time.

Methods: Oocytes were collected from 43 women with polycystic ovary syndrome. Metaphase I (MI) oocytes after in vitro culture for 24 h from germinal vesicle stage were subjected to ICSI according to time after first PB extrusion. The intervals were: within 1 h (n=38); 1-2 h (n=30); 2-4 h (n=26);4-6 (n=28) and 6-8 h (n=40). In some MI oocytes, viable spindle location was evaluated using Polscope microscopy at different time intervals after first PB extrusion.

Results: Fertilization rate of the MI oocytes injected within 1 h after first PB extrusion was low (15.8; 6/38) (P<0.01 versus all other times). In contrast, the fertilization rate was 80, 92.3, 82.1 and 85% for oocytes injected 1-2, 2-4, 4-6 and 6-8 h after first PB extrusion, respectively. Development of good-quality embryos was not significantly different among all the groups. Interestingly, all the oocytes injected within 1 h after first PB extrusion were in Telophase I.

Conclusions: Human oocytes matured in vitro needed at least 1 h after first PB extrusion to complete nuclear maturation. Use of a live spindle imaging system can help to decide the timing of ICSI for oocytes matured in vitro.

Download full-text PDF

Source
http://dx.doi.org/10.1093/humrep/dem124DOI Listing

Publication Analysis

Top Keywords

optimal icsi
8
polar body
8
human oocytes
8
oocytes injected
8
time intervals
8
oocytes
6
icsi timing
4
timing polar
4
extrusion
4
body extrusion
4

Similar Publications

Purpose: Selection of optimal embryo transfer strategies for IVF patients treated with antagonist protocols.

Methods: A retrospective study was conducted to assess whether whole embryo culture to the blastocyst stage could enhance the cumulative live birth rate (CLBR). The study included data from the first oocyte retrieval cycle of 4131 patients who underwent IVF treatment between January 2018 and June 2022.

View Article and Find Full Text PDF

Biosimilars versus the originator of follitropin alfa for ovarian stimulation in ART: a systematic review and meta-analysis.

Hum Reprod

December 2024

Unit for Human Reproduction, 1st Dept of Obstetrics and Gynaecology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Study Question: Is the probability of pregnancy different between women using biosimilars versus the originator of follitropin alfa for ovarian stimulation in ART?

Summary Answer: Meta-analysis of eight randomized clinical trials (RCTs) suggests that live birth, clinical, and ongoing pregnancy rates are significantly lower with biosimilars of follitropin alfa compared to the originator.

What Is Known Already: All biosimilars of follitropin alfa have received regulatory approval by demonstrating non-inferiority in the number of retrieved oocytes compared to the originator. Nevertheless, the most clinically relevant outcome in ART for both clinicians and patients is live birth.

View Article and Find Full Text PDF

The intricate "ART" of ICSI.

J Assist Reprod Genet

December 2024

The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, 1305 York Avenue, Y720, New York, NY, 10021, USA.

Article Synopsis
  • The manuscript discusses the Intracytoplasmic Sperm Injection (ICSI) procedure and highlights insights gained from 30 years of experience in treating male factor infertility at a specialized center.
  • It emphasizes the collaborative efforts of the embryology, andrology, and PGT-A laboratories, which work together with reproductive physicians and urologists to provide comprehensive patient care.
  • The focus is on the andrology lab's crucial role in preparing for ICSI, detailing essential considerations like sperm selection, oocyte conditions, necessary equipment, and the procedure's execution.
View Article and Find Full Text PDF

Background: The ovarian response to gonadotropin stimulation varies widely among women, and could impact the probability of live birth as well as treatment risks. Many studies have evaluated the impact of different gonadotropin starting doses, mainly based on predictive variables like ovarian reserve tests (ORT) including anti-Müllerian hormone (AMH), antral follicle count (AFC), and basal follicle-stimulating hormone (bFSH). A Cochrane systematic review revealed that individualizing the gonadotropin starting dose does not affect efficacy in terms of ongoing pregnancy/live birth rates, but may reduce treatment risks such as the development of ovarian hyperstimulation syndrome (OHSS).

View Article and Find Full Text PDF

Impact of sleep characteristics on IVF/ICSI outcomes: A prospective cohort study.

Sleep Med

November 2024

Department of Reproductive Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China; Hubei Clinical Research Center for Prenatal Diagnosis and Birth Health, Wuhan, China; Wuhan Clinical Research Center for Reproductive Science and Birth Health, Wuhan, China. Electronic address:

Article Synopsis
  • Infertility affects millions and treatments like IVF and ICSI have low success rates (~35% per embryo transfer), prompting researchers to examine how lifestyle factors, particularly sleep, may impact outcomes.
  • A study with 174 women undergoing ART explored the link between sleep quality, stress levels, and the success of IVF/ICSI procedures by analyzing various reproductive metrics.
  • Results indicated that poor sleep quality significantly reduced the number of retrieved oocytes and matured oocytes, with excessive sleep (≥10 hours) leading to even worse outcomes in embryo quality.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!